Literature DB >> 8386314

Upstream basal promoter element important for exclusive RNA polymerase III transcription of the EBER 2 gene.

J G Howe1, M D Shu.   

Abstract

The Epstein-Barr virus-encoded small RNA (EBER) genes are transcribed by RNA polymerase III, but their transcription unit appears to contain both class II and class III promoter elements. One of these promoter element, a TATA-like box which we call the EBER TATA box, or ETAB, is located in a position typical for a class II TATA box but contains G/C residues in the normal T/A motif and a conserved thymidine doublet. Experiments using chloramphenicol acetyltransferase constructs and mutations in the TATA box of the adenovirus major late promoter showed that the ETAB promoter element does not substitute for a class II TATA box. However, when the ETAB promoter element sequence was changed to a class II TATA box consensus sequence, the EBER 2 gene was transcribed in vitro by both RNA polymerases II and III. From these results, we conclude that the ETAB promoter element is important for the exclusive transcription of the EBER 2 gene by RNA polymerase III.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386314      PMCID: PMC359634          DOI: 10.1128/mcb.13.5.2655-2665.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  The cloned RNA polymerase II transcription factor IID selects RNA polymerase III to transcribe the human U6 gene in vitro.

Authors:  S M Lobo; J Lister; M L Sullivan; N Hernandez
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

2.  Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro.

Authors:  C R Wobbe; K Struhl
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  Functional domains and upstream activation properties of cloned human TATA binding protein.

Authors:  M G Peterson; N Tanese; B F Pugh; R Tjian
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

4.  Cloning and structure of a yeast gene encoding a general transcription initiation factor TFIID that binds to the TATA box.

Authors:  M Horikoshi; C K Wang; H Fujii; J A Cromlish; P A Weil; R G Roeder
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

5.  Fine structure genetic analysis of a beta-globin promoter.

Authors:  R M Myers; K Tilly; T Maniatis
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

6.  A distant enhancer element is required for polymerase III transcription of a U6 RNA gene.

Authors:  C Bark; P Weller; J Zabielski; L Janson; U Pettersson
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

7.  Compilation and analysis of eukaryotic POL II promoter sequences.

Authors:  P Bucher; E N Trifonov
Journal:  Nucleic Acids Res       Date:  1986-12-22       Impact factor: 16.971

8.  The capped U6 small nuclear RNA is transcribed by RNA polymerase III.

Authors:  R Reddy; D Henning; G Das; M Harless; D Wright
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

9.  Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells.

Authors:  J R Arrand; L Rymo
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

10.  A short 5' flanking region containing conserved sequences is required for silkworm alanine tRNA gene activity.

Authors:  D Larson; J Bradford-Wilcox; L S Young; K U Sprague
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  14 in total

1.  Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth.

Authors:  M S Kang; S C Hung; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

2.  Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.

Authors:  B Wensing; A Stühler; P Jenkins; M Hollyoake; C E Karstegl; P J Farrell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.

Authors:  I K Ruf; P W Rhyne; C Yang; J L Cleveland; J T Sample
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Efficient transcription of the EBER2 gene depends on the structural integrity of the RNA.

Authors:  Edda Dümpelmann; Hendrik Mittendorf; Bernd-Joachim Benecke
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

5.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.

Authors:  W Zhong; H Wang; B Herndier; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

6.  Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.

Authors:  Misako Yajima; Teru Kanda; Kenzo Takada
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

Authors:  Yu-Hsin Chiu; John B Macmillan; Zhijian J Chen
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

Review 8.  Contributions of in vitro transcription to the understanding of human RNA polymerase III transcription.

Authors:  Hélène Dumay-Odelot; Stéphanie Durrieu-Gaillard; Leyla El Ayoubi; Camila Parrot; Martin Teichmann
Journal:  Transcription       Date:  2014

9.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.

Authors:  Andrea Ablasser; Franz Bauernfeind; Gunther Hartmann; Eicke Latz; Katherine A Fitzgerald; Veit Hornung
Journal:  Nat Immunol       Date:  2009-07-16       Impact factor: 25.606

10.  Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Authors:  Thomas J Owen; John D O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.